These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34552857)

  • 1. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems.
    Elliott MK; Sidhu BS; Mehta VS; Gould J; Martic D; Rinaldi CA
    HeartRhythm Case Rep; 2021 Sep; 7(9):628-632. PubMed ID: 34552857
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging Technologies in Electrophysiology: From Single-Chamber to Biventricular Leadless Pacemakers.
    Gill J
    Cardiology; 2022; 147(2):179-190. PubMed ID: 35038698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis.
    Ito R; Kondo Y; Winter J; Hayashi T; Nakano M; Kajiyama T; Nakano M; Kobayashi Y
    J Arrhythm; 2019 Apr; 35(2):311-313. PubMed ID: 31007801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
    Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
    Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European experience with a first totally leadless cardiac resynchronization therapy pacemaker system.
    Carabelli A; Jabeur M; Jacon P; Rinaldi CA; Leclercq C; Rovaris G; Arnold M; Venier S; Neuzil P; Defaye P
    Europace; 2021 May; 23(5):740-747. PubMed ID: 33313789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-When vascular options have run out.
    Ng JB; Chua K; Teo WS
    J Arrhythm; 2019 Feb; 35(1):136-138. PubMed ID: 30805055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients.
    Auricchio A; Delnoy PP; Regoli F; Seifert M; Markou T; Butter C;
    Europace; 2013 Aug; 15(8):1191-7. PubMed ID: 23703364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Leadless Pacemaker and Subcutaneous ICD Implantation With Intraoperative Screening: Workflow in Two Patients.
    Nieves J; Laslett DB; Basil A; Whitman IR; Cooper JM; Cronin EM
    JACC Case Rep; 2022 Dec; 4(23):101535. PubMed ID: 36507298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completely Leadless Cardiac Resynchronization Defibrillator System.
    Sidhu BS; Gould J; Porter B; Elliott M; Mehta V; Niederer S; Rinaldi CA
    JACC Clin Electrophysiol; 2020 May; 6(5):588-589. PubMed ID: 32439047
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for pacing in patients who qualify for an implantable cardioverter-defibrillator: Clinical implications for the subcutaneous ICD.
    Kutyifa V; Rosero SZ; McNitt S; Polonsky B; Brown MW; Zareba W; Goldenberg I
    Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12744. PubMed ID: 31994819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.
    Tjong FVY; Koop BE
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):355-361. PubMed ID: 30382341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with subcutaneous implantable cardiac defibrillator and leadless pacemaker in a patient with persistent left superior vena cava and mega coronary sinus: A challenging case for the best treatment.
    Gatto MC; De Sanctis V; Percoco F; Persi A; Dominici T; Moretti A; Evangelista F; Mantica M; Kol A
    J Arrhythm; 2021 Oct; 37(5):1364-1367. PubMed ID: 34621440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leadless Cardiac Devices-Pacemakers and Implantable Cardioverter-Defibrillators.
    Rutzen-Lopez H; Silva J; Helm RH
    Curr Treat Options Cardiovasc Med; 2016 Aug; 18(8):49. PubMed ID: 27287746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator.
    Ishii N; Nakajima K; Kakuta T; Noda T; Fujita T; Kusano K
    Intern Med; 2021 Jun; 60(12):1877-1880. PubMed ID: 33518564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
    Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    J Arrhythm; 2016 Feb; 32(1):1-28. PubMed ID: 26949427
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a leadless pacemaker and subcutaneous defibrillator with nine effective shock treatments during follow-up of 18 months.
    Ljungström E; Brandt J; Mörtsell D; Borgquist R; Wang L
    J Electrocardiol; 2019; 56():1-3. PubMed ID: 31226509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.